Company
InvivoPharm, Inc. is a newly established, specialist contract research organization (CRO) located in Long Island, New
York. The core expertise of InvivoPharm is in the areas of receptor occupancy, autoradiography and drug distribution.
However, we strive to be flexible and will be happy to consider related projects provided they are within our capabilities
and ability.
Quality assurance
All projects are performed following a study protocol prepared by InvivoPharm and accepted by the customer prior to
the beginning of the project. Data is typically sent to the customer as it is generated, thus facilitating any needed
modifications in the protocol on the basis of initial results. After completing the project, InvivoPharm prepares a final
report containing all necessary information about the study, including a detailed description of the test system used,
how the test was performed, all results, analysis of the results, conclusions, a quality assurance statement and
archiving statement. Final payment is due upon completion of the report.
Facilities and equipment
Our office and laboratory space are located at the Stony Brook University Technology Incubator at Calverton.
Equipment includes a whole-body cryosectioner (custom-built), tissue cryosectioner, phosphorimager, 12 and 36-well
filtration harvesters, scintillation counters (two) and HPLC. Rodent housing (long term) is via subcontract.
Management
Andy Gifford, Ph.D. (President and Chief Scientific Officer)
In addition to being a founder of the company, Dr. Gifford has served for many years as a scientist in the
radiopharmaceutical development program at Brookhaven National Laboratory and continues to maintain an active
appointment there. As a principal investigator in the program, Dr. Gifford has been responsible for preclinical studies
on a variety of radiolabeled drugs. Techniques employed in his academic laboratories include peptide and drug
radioiodinations, radioligand binding assays, in vivo measurements of receptor occupancy and ex vivo
autoradiography.
Publication list for Dr. Gifford
Alison Liu, Ph.D. (Vice President)
Dr. Liu is a co-founder of the company. She received her Ph.D. from Stony Brook University and has previously held
postdoctoral appointments at both Cold Spring Harbor Laboratory and Rockefeller University. Her academic research
interests have been in the area of pharmacology and neuroscience using knockout and transgenic animal models.
InvivoPharm, Inc. is a newly established, specialist contract research organization (CRO) located in Long Island, New
York. The core expertise of InvivoPharm is in the areas of receptor occupancy, autoradiography and drug distribution.
However, we strive to be flexible and will be happy to consider related projects provided they are within our capabilities
and ability.
Quality assurance
All projects are performed following a study protocol prepared by InvivoPharm and accepted by the customer prior to
the beginning of the project. Data is typically sent to the customer as it is generated, thus facilitating any needed
modifications in the protocol on the basis of initial results. After completing the project, InvivoPharm prepares a final
report containing all necessary information about the study, including a detailed description of the test system used,
how the test was performed, all results, analysis of the results, conclusions, a quality assurance statement and
archiving statement. Final payment is due upon completion of the report.
Facilities and equipment
Our office and laboratory space are located at the Stony Brook University Technology Incubator at Calverton.
Equipment includes a whole-body cryosectioner (custom-built), tissue cryosectioner, phosphorimager, 12 and 36-well
filtration harvesters, scintillation counters (two) and HPLC. Rodent housing (long term) is via subcontract.
Management
Andy Gifford, Ph.D. (President and Chief Scientific Officer)
In addition to being a founder of the company, Dr. Gifford has served for many years as a scientist in the
radiopharmaceutical development program at Brookhaven National Laboratory and continues to maintain an active
appointment there. As a principal investigator in the program, Dr. Gifford has been responsible for preclinical studies
on a variety of radiolabeled drugs. Techniques employed in his academic laboratories include peptide and drug
radioiodinations, radioligand binding assays, in vivo measurements of receptor occupancy and ex vivo
autoradiography.
Publication list for Dr. Gifford
Alison Liu, Ph.D. (Vice President)
Dr. Liu is a co-founder of the company. She received her Ph.D. from Stony Brook University and has previously held
postdoctoral appointments at both Cold Spring Harbor Laboratory and Rockefeller University. Her academic research
interests have been in the area of pharmacology and neuroscience using knockout and transgenic animal models.
 | |  | |  |
Preclinical contract research services
